+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

Global Bariatric Surgery Devices Market Set To Grow To $1.5bn By 2023

02 August 2018
Pharma

Visiongain’ has launched a new pharma report Bariatric Surgery Devices Market Report : Assisting Devices, Implantable Devices, Suturing Devices, Stapling Devices, Closure Devices, Trocars, Gastric Bands, Intragastric Balloons, Single Intragastric Balloons, Dual Intragastric Balloons, Triple Intragastric Balloons, Electrical Stimulation Devices, Gastric Emptying, Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, Bariatric Surgery Clinics, Ambulatory Surgical Centres, Hospital Pharmacies

The bariatric surgery devices market is expected to witness a significant growth over the forecast period. The main drivers for the growth include rapid growth in the number of obese patients, growing incidences of obesity-related chronic disorders, and technological innovations in bariatric surgery systems. Additionally, government initiatives to curb obesity and related problems along with insurance coverage for bariatric procedures will further contribute to the growth of the market.

The lead analyst of the report commented “The demand for minimal invasive surgeries is growing rapidly as they save time, cost, and reduced hospital stay. In addition to this, governments are also encouraging the adoption of minimal invasive surgeries to lower the incidences of infection. Key players are striving to change the traditional methods of surgeries and developing innovative techniques to enable surgeons to perform bariatric surgeries more effectively.”

Leading companies featured in the report include Johnson & Johnson, Aspire Bariatrics, Inc.
GI Dynamics, Inc., Intuitive Surgical, Inc., Medtronic plc, Apollo Endosurgery, Inc., Mediflex, Cousin Biotech, Spatz FGIA Inc., The DACH Medical Group Holding AG (DACH), EnteroMedics Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read